comparemela.com

Latest Breaking News On - Cerflux inc - Page 1 : comparemela.com

BCRFA invests $1 25M into Alabama breast cancer research projects

The Breast Cancer Research Foundation of Alabama has made a major investment into thirty five research projects scattered throughout the state. The organization said that in 2023 alone it dispensed grants worth a cumulative total of $1.25 million in an effort to support the various projects.

$1 25 million investment powers Alabama s top institutions in tackling breast cancer - News

BCRFA continues to provide substantial gifts to the O’Neal Comprehensive Cancer Center to accelerate breast cancer research. Written by: Wright Wiggins RouseMedia contact: Brianna Hoge Barry P. Sleckman, Ph.D., Photograp.

Innovate Alabama opens second round of grant funding to benefit Alabama entrepreneurs

Innovate Alabama opens second round of grant funding to benefit Alabama entrepreneurs
alabamanewscenter.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from alabamanewscenter.com Daily Mail and Mail on Sunday newspapers.

Innovate Alabama awards more than $4 5 million in small business grants

Innovate Alabama awards more than $4 5 million in small business grants
thebamabuzz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thebamabuzz.com Daily Mail and Mail on Sunday newspapers.

CERFLUX Announces Breast Cancer Research Foundation of Alabama Award

CERFLUX Announces Breast Cancer Research Foundation of Alabama Award Share Article BIRMINGHAM, Ala. (PRWEB) December 18, 2020 CerFlux, creators of an advanced personalized medicine solutions to identify the most efficient and effective cancer treatments for each patient on an individualized basis, announced today the receipt of a $50,000 Breast Cancer Research Foundation of Alabama (BCRFA) grant to help fund new imaging technology at the CerFlux lab in downtown Birmingham. This imaging technology will provide the added efficiency critical for processing breast cancer tumor specimens in the CerFlux Personalized Oncology Efficacy Test (POET). The personalized medicine approach at the heart of POET addresses the critical, urgent, and unmet need for accessible and affordable predictive tools that identify optimal systemic therapy regimens and eliminate ineffective options. By providing an individualized treatment pla

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.